For IBS patients, although they do not manifest histological aberration, there is now good evidence for low grade inflammation and immune activation [34], [35] including the increase in the intestinal level of CD3, CD4 and CD8 cells [36]–[38]. The gene discussed is CD8A; the disease is irritable bowel syndrome.